分類彙整：公司新聞

今(19)日衛福部長陳時中率國家防疫團隊之政委吳政忠、台大副校長張上淳等人訪察聯合生物製藥(股份有限)公司(以下稱聯生藥)，以了解UBI/聯亞集團所開發的新冠疫苗開發進度，及擬作為委託生產基地聯生藥的生產產能。 繼續閱讀 →

Testing in the ski town Telluride could allow for fewer restrictions nationwide. 繼續閱讀 →

Telluride, CO (March 19, 2020) –United Biomedical, Inc. (UBI) and its subsidiary c19 are taking on the COVID-19 pandemic by partnering with San Miguel County, Colorado, to be the first in the United States to test an entire county with their COVID-19 antibody test for the SARS-CoV-2 virus. The testing is being offered free of charge by UBI and c19 and will be administered by the Public Health Department of San Miguel County, with the goal of detecting and containing community spread, and providing a more accurate assessment of disease prevalence. 繼續閱讀 →

Who is the UBI Group? 

UBI Group was founded in 1985 and currently has over 5 operating entities and 950 employees globally. We have facilities in China, Taiwan, Ireland and the US. For the past three decades, we have developed, manufactured and sold HIV, HCV, HTLV and FMDV blood diagnostic kits worldwide through various distribution partners including Organon Teknika and BioMerieux. We have also developed, manufactured and sold over 4.5 billion vaccines and ~500 million doses annually through partners. Dr. Chang Yi Wang, our Chief Scientific Officer, is inventor and author of over 100 patents and peer-reviewed publications. She has, together with the UBI team, pioneered the employment of antigenic peptides in the development of  4 blood screening test kits for detection of antibodies to HIV, HCV, HTLV I/II and FMDV for identification and differentiation of viral infections and 2 licensed synthetic peptide based vaccines (FMDV and LHRH) which are globally distributed. She has been awarded Inventor of the Year Award (NYPLA), Pioneer in Technology Award (BMSF), and recipient of funding from Gates Foundation, MOEA and multiple NIH grants over $20M, including for SARS antibody screening diagnostic work. She is currently collaborating with Dr. Anthony Fauci/NIAID and colleagues on HIV functional cure program, and discussed extensively with Dr. Redfield in this area, both leaders in the coronavirus response today.  繼續閱讀 →

科羅拉多州的聖米格爾縣是一個很小的縣，居民人數只有8000人，縣裡沒有醫院，公共衛生部門只有3位職員。在縣內有一個小鎮叫做特柳賴德鎮，這個小鎮雖然小，卻是一個旅遊勝地，經常有來來往往的旅客，因此使得居民暴露在新冠肺炎傳染的風險中。

聯合生物醫學公司 (United Biomedical) 的執行長及共同創辦人Mei Mei Hu和Lou Reese夫婦居住在特柳賴德鎮，當他們夫婦得知小鎮醫療資源不足後，就答應捐贈新冠肺炎篩檢的套件，讓聖米格爾縣的所有居民都能接受篩檢。 繼續閱讀 →

San Miguel County in Colorado has, in ordinary times, fewer than three full-time employees in its public-health department. It has no hospital. Its total population is only 8,000. And yet last week, the county became the first in the United States to announce that it would be offering all its residents a new kind of test for COVID-19. 繼續閱讀 →

聯亞生技集團於3月19日受新竹科學園區管理局之邀請參加記者會，於記者會由聯亞藥業研發營運長彭文君博士代表集團發表有關COVID-19檢測試劑、疫苗及治療藥物之近期開發進度。

新冠肺炎(COVID-19)疫情自2019年底爆發至今，情勢愈益嚴峻，疫情仍正加速在全球升溫，為了這場與新冠肺炎病毒的超級戰役，UBI集團董事長暨科學長王長怡博士與團隊投入對2019-nCoV病毒的抗體診斷試劑及對抗COVID-19的疫苗與治療藥物之設計，運用其在功能性抗原學逾30年的研究與商業化經驗，以及在重組蛋白藥物領域的20年產業經驗，展開一系列的產品開發計畫，包括： 繼續閱讀 →

檢測試劑來了！　美FDA授權開賣 繼續閱讀 →